Literature DB >> 23538775

Bone metabolism compensates for the delayed growth in small for gestational age neonates.

Roxane Tenta1, Ifigeneia Bourgiezi, Evangelos Aliferis, Magdalini Papadopoulou, Antonis Gounaris, Maria Skouroliakou.   

Abstract

The goal of the present study is to investigate the relationship between anthropometric and bone metabolism markers in a sample of neonates and their mothers. A sample of 20 SGA (small for the gestational age), AGA (appropriate for the gestational age) and LGA (large for the gestational age) term neonates and their 20 mothers was analyzed at birth and at exit. Elisa method was used to measure the OPG (Osteoprotegerin), RANK (Receptor activator of nuclear factor-kappaB), RANKL (Receptor activator of nuclear factor-kappaB Ligand), IGF-1 (Insulin-like growth factor 1), IGFBP3 (Insulin-like Growth Factor Binding Protein 3) and Leptin levels. Birth weight and length were positively correlated with RANKL, IGF-1 and IGFBP3 and negatively with the ratio OPG/RANKL. SGA neonates presented lower RANKL values and higher OPG/RANKL ratio while LGA neonates had higher RANK levels than AGA neonates. Positive association was shown between neonatal IGFBP3 and maternal IGF-1 values and between neonatal and maternal RANK values at birth and at exit. These results reveal a remarkable upregulation of OPG/RANKL ratio in SGA neonates, pointing out the role of bone turnover in compensating for the delayed neonatal growth.

Entities:  

Keywords:  IGF-1; Leptin; OPG; RANKL; neonates

Mesh:

Substances:

Year:  2013        PMID: 23538775      PMCID: PMC3674041          DOI: 10.4161/org.24251

Source DB:  PubMed          Journal:  Organogenesis        ISSN: 1547-6278            Impact factor:   2.500


  22 in total

Review 1.  The insulin-like growth factor-binding protein (IGFBP) superfamily.

Authors:  V Hwa; Y Oh; R G Rosenfeld
Journal:  Endocr Rev       Date:  1999-12       Impact factor: 19.871

2.  Relationship of insulin-like growth factor-I, insulin-like growth factor binding protein-3, insulin, growth hormone in cord blood and maternal factors with birth height and birthweight.

Authors:  S W Yang; J S Yu
Journal:  Pediatr Int       Date:  2000-02       Impact factor: 1.524

3.  Influence of prematurity and growth restriction on the adipokine profile, IGF1, and ghrelin levels in cord blood: relationship with glucose metabolism.

Authors:  Gabriel A Martos-Moreno; Vicente Barrios; Miguel Sáenz de Pipaón; Jesús Pozo; Izaskun Dorronsoro; Miriam Martínez-Biarge; José Quero; Jesús Argente
Journal:  Eur J Endocrinol       Date:  2009-06-26       Impact factor: 6.664

4.  Comparison of bone metabolic markers between maternal and cord blood.

Authors:  A Yamaga; M Taga; S Hashimoto; C Ota
Journal:  Horm Res       Date:  1999-12

5.  Expression and protein content of IGF-I and IGF-I receptor in placentas from small, adequate and large for gestational age newborns.

Authors:  G Iñiguez; C A González; F Argandoña; E Kakarieka; M C Johnson; F Cassorla
Journal:  Horm Res Paediatr       Date:  2010-04-14       Impact factor: 2.852

Review 6.  Central control of bone formation.

Authors:  S Takeda; G Karsenty
Journal:  J Bone Miner Metab       Date:  2001       Impact factor: 2.626

7.  The influence of folic acid supplementation on maternal and fetal bone turnover.

Authors:  Arash Hossein-nezhad; Khadijeh Mirzaei; Zhila Maghbooli; Azam Najmafshar; Bagher Larijani
Journal:  J Bone Miner Metab       Date:  2010-07-03       Impact factor: 2.626

8.  Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers.

Authors:  H Uemura; T Yasui; M Kiyokawa; A Kuwahara; H Ikawa; T Matsuzaki; M Maegawa; H Furumoto; M Irahara
Journal:  J Endocrinol       Date:  2002-08       Impact factor: 4.286

9.  Relation of cord serum levels of growth hormone, insulin-like growth factors, insulin-like growth factor binding proteins, leptin, and interleukin-6 with birth weight, birth length, and head circumference in term and preterm neonates.

Authors:  Hui-Chen Lo; Lon-Yen Tsao; Wen-Yin Hsu; Hsia-Nan Chen; Wai-Kit Yu; Chiu-Yen Chi
Journal:  Nutrition       Date:  2002 Jul-Aug       Impact factor: 4.008

10.  Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction.

Authors:  Despina D Briana; Maria Boutsikou; Stavroula Baka; Demetrios Hassiakos; Demetrios Gourgiotis; Ariadne Malamitsi-Puchner
Journal:  Neonatology       Date:  2009-04-08       Impact factor: 4.035

View more
  3 in total

1.  Maternal RANKL Reduces the Osteopetrotic Phenotype of Null Mutant Mouse Pups.

Authors:  Benjamin Navet; Jorge William Vargas-Franco; Andrea Gama; Jérome Amiaud; Yongwon Choi; Hideo Yagita; Christopher G Mueller; Françoise Rédini; Dominique Heymann; Beatriz Castaneda; Frédéric Lézot
Journal:  J Clin Med       Date:  2018-11-08       Impact factor: 4.241

2.  Mechanisms by which sialylated milk oligosaccharides impact bone biology in a gnotobiotic mouse model of infant undernutrition.

Authors:  Carrie A Cowardin; Philip P Ahern; Vanderlene L Kung; Matthew C Hibberd; Jiye Cheng; Janaki L Guruge; Vinaik Sundaresan; Richard D Head; Daniela Barile; David A Mills; Michael J Barratt; Sayeeda Huq; Tahmeed Ahmed; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

3.  Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study.

Authors:  Helena Schock; Anne Zeleniuch-Jacquotte; Eva Lundin; Kjell Grankvist; Hans-Åke Lakso; Annika Idahl; Matti Lehtinen; Heljä-Marja Surcel; Renée T Fortner
Journal:  BMC Pregnancy Childbirth       Date:  2016-07-04       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.